Shariah compliance overview
Not HalalTango Therapeutics, Inc. (TNGX) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Tango Therapeutics, Inc.
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5).
Tango Therapeutics, Inc. (TNGX) operates in the Healthcare sector, in the Biotechnology industry.
Why it is not classified as halal: it does not pass these screens: Business Activity.
- Business Activity
- 8.28%Limit 5%Fail
- Interest-bearing debt
- 2.41%Limit 30%Pass
- Interest-bearing securities and assets
- 26.77%Limit 30%Pass
- Dividend purification
- 8.28%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Tango Therapeutics, Inc. (TNGX). Current Akinda screening label: Not Halal.
